MedTrace Logo

Efficacy of Etoricoxib on Peripheral Hyperalgesia

NCT01088256 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2012-08-24

No results posted yet for this study

Summary

The purpose of the study is to determine the efficacy of etoricoxib on pain patients. The investigators assume that patients with neuropathic pain will have greater pain relief then patients on placebo.

Conditions

  • Causalgia
  • Polyneuropathy
  • Postherpetic Neuralgia
  • Peripheral Nerve Injury
  • Radiculopathy

Interventions

DRUG

Etoricoxib

the patients get etoricoxib 90mg for 8 days. They get one pill with 90mg per day

DRUG

placebo

patients get one pill of placebo (sugar-pill) per day for 8 days.

Sponsors & Collaborators

  • Ruhr University of Bochum

    lead OTHER

Principal Investigators

  • Christoph Maier, Dr.med · University hospital Bergmannsheil department of pain therapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01088256 on ClinicalTrials.gov